Related references
Note: Only part of the references are listed.Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
Amir A. Al-Khami et al.
ONCOIMMUNOLOGY (2017)
Characterization of an Acellular Scaffold for a Tissue Engineering Approach to the Nipple-Areolar Complex Reconstruction
Nicholas C. Pashos et al.
CELLS TISSUES ORGANS (2017)
Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer Medicine
H. Charles Manning et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
Fresia Pareja et al.
NPJ BREAST CANCER (2016)
Molecular Portrait of Breast-Cancer-Derived Cell Lines Reveals Poor Similarity with Tumors
Paolo Cifani et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
Pascal Jezequel et al.
BREAST CANCER RESEARCH (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators
Lyndsay V. Rhodes et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Overview of Breast Cancer Collaborative Stage Data Items-Their Definitions, Quality, Usage, and Clinical Implications: A Review of SEER Data for 2004-2010
Nadia Howlader et al.
CANCER (2014)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity
Ingrid A. Mayer et al.
CLINICAL CANCER RESEARCH (2014)
Picrosirius Red Staining: A Useful Tool to Appraise Collagen Networks in Normal and Pathological Tissues
Raed Lattouf et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Renaud Sabatier et al.
MOLECULAR CANCER (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Triple-Negative Breast Cancer and the Need for New Therapeutic Targets
Olav Engebraaten et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Genetic Susceptibility to Triple-Negative Breast Cancer
Kristen N. Stevens et al.
CANCER RESEARCH (2013)
Patient-derived breast tumor xenografts facilitating personalized cancer therapy
Melissa D. Landis et al.
BREAST CANCER RESEARCH (2013)
Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
Basem Azab et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
Scott Kopetz et al.
CLINICAL CANCER RESEARCH (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Molecular profiling of patient-derived breast cancer xenografts
Fabien Reyal et al.
BREAST CANCER RESEARCH (2012)
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Alyssa D. Gregory et al.
CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Jean-Pierre Gillet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Ketao Jin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Gr-1+CD11b+ Myeloid-Derived Suppressor Cells: Formidable Partners in Tumor Metastasis
Li Yang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Iduna Fichtner et al.
CLINICAL CANCER RESEARCH (2008)
Breast cancer cell lines: friend or foe?
SE Burdall et al.
BREAST CANCER RESEARCH (2003)
Share Paper
